ADOCIA

Compositions in the form of an injectable aqueous solution comprising at least human insulin A2IG and a prandial action glucagon suppressor

N° AU2025203948A1

Compositions In The Form Of An Injectable Aqueous Solution Comprising Human Glucagon And A Copolyamino Acid

N° AU2025201936A1

COMPOSITION COMPRISING A PEPTIDE HAVING AN ISOELECTRIC POINT OF LESS THAN 6.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° WO2025172605A1

COMPOSITION COMPRISING SEMAGLUTIDE, CAGRILINTIDE AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° WO2025172606A1

BICOMPONENT GLUE

N° WO2025153726A1

THERMOSTABLE FORMULATION OF A21G HUMAN INSULIN

N° US2025099551A1

Compositions In The Form Of An Injectable Aqueous Solution Comprising Amylin, An Amylin Receptor Agonist Or An Amylin Analog And A Copolyamino Acid

N° AU2024278135A1

COMPOSITIONS IN FORM OF INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AMYLIN RECEPTOR AGONIST OR AMYLIN ANALOG AND COPOLYAMINO ACID

N° JP2025032188A

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN AGONIST RECEPTOR OR AN AMYLIN ANALOGUE AND A CO-POLYAMINO ACID

N° US2025090638A1

COMPOSITION COMPRISING SEMAGLUTIDE, CAGRILINTIDE AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° EP4603080A1

COMPOSITION COMPRISING A PEPTIDE HAVING AN ISOELECTRIC POINT OF LESS THAN 6.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° EP4603079A1

INJECTABLE SOLUTION WITH PH OF 7 COMPRISING AT LEAST ONE BASAL INSULIN WITH PI OF BETWEEN 5.8 AND 8.5 AND CO-POLYAMINOACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° JP2024059696A

INJECTABLE SOLUTION WITH PH OF 7 COMPRISING AT LEAST ONE BASAL INSULIN WITH PI OF BETWEEN 5.8 AND 8.5 AND CO-POLYAMINOACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° JP2024059693A

HYDROGELS FOR CELL THERAPY

N° EP4588488A1

COMPOSITIONS COMPRISING AT LEAST AN INSULIN AND AN AMYLIN RECEPTOR AGONIST FOR TREATING DIABETES, IN A PATIENT/PERSON HAVING A BMI OF MORE THAN 28 KG/M² AND/OR AN HBA1C OF MORE THAN 7.6%

N° US2024115663A1

Hydrogels for cell therapy

N° CN119855837A

HYDROGELS FOR CELL THERAPY

N° EP4554983A1

HYDROGELS FOR CELL THERAPY

N° WO2024013355A1

HYDROGELS FOR DRUG DELIVERY

N° WO2024013354A1

HYDROGELS FOR CELL THERAPY

N° AU2023305102A1

세포 치료를 위한 하이드로겔

N° KR20250050883A

HYDROGELS FOR CELL THERAPY

N° WO2024013353A1

Hydrogels for cell therapy

N° CN119948065A

Hydrogels for cell therapy

N° IL304353A

COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID

N° WO2024003400A1

COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID

N° EP4547267A1

Compositions comprising peptides or proteins and acylated amino acids

N° CN119486752A

FAST ACTING INSULIN FORMULATION COMPRISING SUBSTITUTED ANIONIC COMPOUND

N° JP2023099873A

Compositions in the form of an injectable aqueous solution comprising at least human insulin A21G and a prandial action glucagon suppressor

N° AU2023202831A1

COMPOSITIONS IN FORM OF INJECTABLE AQUEOUS SOLUTION COMPRISING AT LEAST HUMAN INSULIN A21G AND PRANDIAL ACTION GLUCAGON SUPPRESSOR

N° JP2023078143A

IMPLANTABLE DEVICE COMPRISING A HYDROGEL

N° WO2023118599A1

SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID

N° WO2023084118A1

SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID

N° EP4433093A1

SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID

N° US2025000948A1

Solid composition comprising peptide or protein and acylated amino acid

N° CN118488855A

COMPOSITIONS COMPRISING AT LEAST AN INSULIN AND AN AMYLIN RECEPTOR AGONIST FOR TREATING DIABETES, IN A PATIENT/PERSON HAVING A BMI OF MORE THAN 28 KG/M² AND/OR AN HBA1C OF MORE THAN 7.6 %

N° EP4342486A1

HYDROGELS FOR CELL THERAPY

N° EP4306548A1

HYDROGELS FOR DRUG DELIVERY

N° EP4306547A1

HYDROGELS FOR CELL THERAPY

N° EP4306549A1

HYDROGELS FOR CELL THERAPY

N° EP4306550A1

COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID

N° EP4299071A1

SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND A PERMEATION ENHANCER

N° EP4299052A1

SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID

N° EP4299057A1

COMPOSITIONS COMPRISING SHORT-ACTING HORMONES FOR TREATING OR PREVENTING OBESITY AND PUMPS COMPRISING SAID COMPOSITION

N° WO2022248419A2

Polímero de dextrano reticulado, hidrogel, uso terapêutico do mesmo, e implante

N° BR112023013816A2

HYDROGELS FOR CELL THERAPY

N° WO2022148887A1

HYDROGELS FOR CELL THERAPY.

N° MX2023008087A

HYDROGELS FOR CELL THERAPY

N° CA3203991A1

세포 치료용 하이드로겔

N° KR20230131885A

HYDROGELS FOR CELL THERAPY

N° EP4274855A1

HYDROGELS FOR CELL THERAPY

N° US2022220228A1

IMPLANTABLE DEVICE COMPRISING A HYDROGEL

N° EP4201440A1

SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID

N° EP4180060A1

COMPOSITIONS COMPRISING SHORT-ACTING HORMONES FOR TREATING OR PREVENTING OBESITY AND PUMPS COMPRISING SAID COMPOSITION

N° EP4144362A1

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID

N° US2021386830A1

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid

N° US2021401943A1

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A CO-POLYAMINO ACID

N° US2022409523A1

COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST

N° EP4129324A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° WO2021240006A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° EP4157321A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° EP4157322A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° CA3180746A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° US2023201312A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° WO2021240004A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° US2023210957A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION.

N° MX2022015084A

COMPOSITIONS COMPRISING SHORT-ACTING HORMONES FOR TREATING OR PREVENTING OBESITY AND PUMPS COMPRISING SAID COMPOSITION

N° EP4091625A1

PH 7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN OF WHICH THE PI IS FROM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS AND A LIMITED AMOUNT OF M-CRESOL

N° US2021205417A1

COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST

N° EP4096702A1

COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST

N° WO2021152184A1

COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST

N° US2023061959A1

HYDROGELS FOR CELL THERAPY

N° EP4026853A1

Rapid-acting insulin formulation comprising a substituted anionic compound

N° US2021060133A1

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A COPOLYAMINO ACID

N° MX2025008231A

Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

N° US2020306379A1

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID

N° US2020306346A1

INJECTABLE SOLUTION AT PH 7 CONTAINING AT LEAST ONE BASAL INSULIN, THE PI OF WHICH IS BETWEEN 5.8 AND 8.5, LIRAGLUTIDE, AND A COPOLYAMINO ACID CARRYING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° WO2020245470A1

Injectable solution at ph 7 comprising at least one basal insulin having a pi of between 5.8 and 8.5 and a copolyamino acid carrying carboxylate charges and hydrophobic radicals

N° IL275192A

Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acid

N° IL275184A

INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN HAVING A PI OF BETWEEN 5.8 AND 8.5 AND A CO-POLYAMINO ACID CARRYING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° SA520412141B1

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID

N° SA520412140B1

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN AGONIST RECEPTOR OR AN AMYLIN ANALOG AND A CO-POLYAMINO ACID

N° SA520412138B1

INJECTABLE SOLUTION WITH A PH 7 OF 7 COMPRISING AT LEAST ONE BASAL INSULIN WITH A PI OF BETWEEN 5.8 AND 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° SA520412142B1

INJECTABLE SOLUTION WITH A PH OF 7 COMPRISING AT LEAST ONE BASAL INSULIN WITH A PI OF BETWEEN 5.8 AND 8.5 AND A CO-POLYAMINOACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° PH12020550803A1

INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN HAVING A PI OF BETWEEN 5.8 AND 8.5 AND A COPOLYAMINO ACID CARRYING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

N° PH12020550827A1

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid

N° IL275146A

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A COPOLYAMINO ACID

N° PH12020550828A1

Injectable solution with a ph of 7 comprising at least one basal insulin with a pi of between 5.8 and 8.5 and a co-polyaminoacid bearing carboxylate charges and hydrophobic radicals

N° IL275148A

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A COPOLYAMINO ACID

N° PH12020550804A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° EP3915572A1

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

N° EP3915571A1

QUICK-ACTING INSULIN FORMULATION INCLUDING A SUBSTITUTED ANIONIC COMPOUND

N° ZA202003132B

Substituted anionic compounds consisting of a backbone consisting of a discrete number of saccharide units

N° AU2020203078A1

Quick-acting insulin formulation including a substituted anionic compound

N° IL274077A

Rapid-acting insulin formulation comprising a substituted anionic compound

N° US2020237877A1

Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action

N° US2020188487A1

COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST

N° EP3858373A1

Compositions in the form of an injectable aqueous solution comprising at least human insulin a21g and a prandial action glucagon suppressor

N° IL272141A

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AT LEAST HUMAN INSULIN A21G AND A PRANDIAL ACTION GLUCAGON SUPPRESSOR

N° PH12020500122A1

PH 7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN OF WHICH THE PI IS FROM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS AND A LIMITED AMOUNT OF M-CRESOL

N° WO2020115333A1